LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank77
3Y CAGR+150.2%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+150.2%/yr
Quarterly compound
Percentile
P77
Within normal range
vs 3Y Ago
15.7x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 23.16% |
| Q2 2025 | 27.30% |
| Q1 2025 | -75.13% |
| Q4 2024 | 14.30% |
| Q3 2024 | 32.40% |
| Q2 2024 | 33.46% |
| Q1 2024 | -14.15% |
| Q4 2023 | -60.22% |
| Q3 2023 | -167.37% |
| Q2 2023 | 61.77% |
| Q1 2023 | -71.50% |
| Q4 2022 | 67.72% |
| Q3 2022 | 1.48% |
| Q2 2022 | 4.22% |
| Q1 2022 | -47.90% |
| Q4 2021 | 13.00% |
| Q3 2021 | -30.96% |
| Q2 2021 | -72.77% |
| Q1 2021 | -43.12% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |